Dengue fever is a mosquito-borne tropical disease caused by the dengue virus. Symptoms typically begin three to fourteen days after infection.  These may include a high fever , headache , vomiting , muscle and joint pains , and a characteristic skin rash .
- Dengue Virus
Dengue virus (DENV) is the cause of dengue fever.It is a...
- Dengue Virus
Dengue fever (pronounced "DEN-gi") is a tropical infectious disease caused by the dengue virus. People get the dengue virus from mosquitoes. Dengue fever is also called break-bone fever, because it can cause so much pain that people feel like their bones are breaking. Most people with dengue fever can get better just by drinking enough.
- Use in other media
Dengue Fever is an American band from Los Angeles who combine Cambodian rock and pop music of the 1960s and 70s with psychedelic rock and other world music styles.
In the late 1990s, keyboardist Ethan Holtzman discovered Cambodian psychedelic rock music while traveling in that country. Coincidentally, his guitarist brother Zac Holtzman had discovered the same music while working at a record store. The brothers formed Dengue Fever in 2001 to perform covers of songs by Cambodian artists like Sinn Sisamouth, Ros Serey Sothea, Pen Ran, and others, most of whom died or disappeared during the Khmer Rouge regime. The band first recruited bassist Senon Williams, f
"Ethanopium", a cover of a song by Ethiopian jazz musician Mulatu Astatke, was included in the soundtrack of Jim Jarmusch's 2005 film Broken Flowers. "One Thousand Tears of a Tarantula" was included on the soundtrack for the second-season finale of the Showtime series Weeds, as well as on the recap of that episode for the third season. The band's Khmer cover of Joni Mitchell's "Both Sides Now" was included on the soundtrack of Matt Dillon's 2002 film set in Cambodia, City of Ghosts. "Seeing Hand
Dengue fever is a disease caused by one of a number of viruses that are carried by mosquitoes. These mosquitoes then transmit the virus to humans.
Dengue vaccine is a vaccine used to prevent dengue fever in humans. As of 2019, one version is commercially available, known as CYD-TDV, and sold under the brand name Dengvaxia. The vaccine is only recommended in those who have previously had dengue fever or populations in which most people have been previously infected.
The viral diseases yellow fever, dengue fever, Zika fever and chikungunya are transmitted mostly by Aedes aegypti mosquitoes.
- The Virus
- The Mosquito
- The Human
The dengue virus (DEN) comprises four distinct serotypes (DEN-1, DEN-2, DEN-3 and DEN-4) which belong to the genus Flavivirus, family Flaviviridae. Distinct genotypes have been identified within each serotype, highlighting the extensive genetic variability of the dengue serotypes. Among them, “Asian” genotypes of DEN-2 and DEN-3 are frequently associated with severe disease accompanying secondary dengue infections.
The Aedes aegypti mosquito is the main vector that transmits the viruses that cause dengue. The viruses are passed on to humans through the bites of an infective female Aedesmosquito, which mainly acquires the virus while feeding on the blood of an infected person. 1. Learn more on the mosquito
Once infected, humans become the main carriers and multipliers of the virus, serving as a source of the virus for uninfected mosquitoes. The virus circulates in the blood of an infected person for 2-7 days, at approximately the same time that the person develops a fever. Patients who are already infected with the dengue virus can transmit the infection via Aedesmosquitoes after the first symptoms appear (during 4-5 days; maximum 12). In humans recovery from infection by one dengue virus provides lifelong immunity against that particular virus serotype. However, this immunity confers only partial and transient protection against subsequent infection by the other three serotypes of the virus. Evidence points to the fact that sequential infection increases the risk of developing severe dengue. The time interval between infections and the particular viral sequence of infections may also be of importance. 1. Read more on symptoms, treatment, prevention and control
- Risk Factors
Dengue (DENG-gey) fever is a mosquito-borne disease that occurs in tropical and subtropical areas of the world. Mild dengue fever causes a high fever, rash, and muscle and joint pain. A severe form of dengue fever, also called dengue hemorrhagic fever, can cause severe bleeding, a sudden drop in blood pressure (shock) and death.Millions of cases of dengue infection occur worldwide each year. Dengue fever is most common in Southeast Asia and the western Pacific islands, but the disease has bee...
Many people, especially children and teens, may experience no signs or symptoms during a mild case of dengue fever. When symptoms do occur, they usually begin four to seven days after you are bitten by an infected mosquito.Dengue fever causes a high fever — 104 F degrees — and at least two of the following symptoms: 1. Headache 2. Muscle, bone and joint pain 3. Nausea 4. Vomiting 5. Pain behind the eyes 6. Swollen glands 7. RashMost people recover within a week or so. In some cases, symptoms...
Dengue fever is caused by any one of four types of dengue viruses spread by mosquitoes that thrive in and near human lodgings. When a mosquito bites a person infected with a dengue virus, the virus enters the mosquito. When the infected mosquito then bites another person, the virus enters that person's bloodstream.After you've recovered from dengue fever, you have immunity to the type of virus that infected you — but not to the other three dengue fever virus types. The risk of developing seve...
Factors that put you at greater risk of developing dengue fever or a more severe form of the disease include: 1. Living or traveling in tropical areas. Being in tropical and subtropical areas increases your risk of exposure to the virus that causes dengue fever. Especially high-risk areas are Southeast Asia, the western Pacific islands, Latin America and the Caribbean. 2. Prior infection with a dengue fever virus. Previous infection with a dengue fever virus increases your risk of having seve...
If severe, dengue fever can damage the lungs, liver or heart. Blood pressure can drop to dangerous levels, causing shock and, in some cases, death.
One dengue fever vaccine, Dengvaxia, is currently approved for use in those ages 9 to 45 who live in areas with a high incidence of dengue fever. The vaccine is given in three doses over the course of 12 months. Dengvaxia prevents dengue infections slightly more than half the time.The vaccine is approved only for older children because younger vaccinated children appear to be at increased risk of severe dengue fever and hospitalization two years after receiving the vaccine.The World Health Or...